| Literature DB >> 30196444 |
Ersi Voskaridou1, Antonis Kattamis2, Christina Fragodimitri3, Alexandra Kourakli4, Panagiota Chalkia5, Michael Diamantidis6, Efthymia Vlachaki7, Marouso Drosou8, Stilianos Lafioniatis9, Konstantinos Maragkos10, Fotini Petropoulou11, Eftihios Eftihiadis12, Marina Economou7, Evangelos Klironomos13, Freideriki Koutsouka14, Konstantina Nestora15, Ioanna Tzoumari16, Ourania Papageorgiou17, Artemis Basileiadi18, Ioannis Lafiatis19, Efthimia Dimitriadou20, Anastasia Kalpaka21, Chrysoula Kalkana22, Georgios Xanthopoulidis23, Ioannis Adamopoulos24, Panagiotis Kaiafas25, Aikaterini Mpitzioni26, Anastasia Goula27, Ioannis Kontonis28, Chrisoula Alepi29, Athanasios Anastasiadis30, Margarita Papadopoulou31, Polixeni Maili32, Dionisia Dionisopoulou33, Antigoni Tsirka34, Alexandros Makis35, Stavroula Kostaridou36, Marianna Politou37, Ioannis Papassotiriou38.
Abstract
National registries constitute an invaluable source of information and contribute to the improvement of hemoglobinopathy management. Herein, we present the second updated report of the National Registry for Haemoglobinopathies in Greece (NRHG) and critically discuss the time trends in demographics, affected births, and causes of mortality. Thirty-eight Greek hemoglobinopathy units reported data from diagnosis to the last follow-up or death by retrospectively completing an electronic form. Four thousand thirty-two patients were eligible for inclusion; more than half of them had thalassaemia major. Compared to the previous report, a reduction in the total number of all hemoglobinopathies except for hemoglobinopathy "Η" was evident. The total number of affected births was also reduced; most of them were attributable to diagnostic errors and lack of awareness. Importantly, data on iron overload are reported for the first time; although most patients had low or moderate liver iron concentration (LIC) values, a non-negligible proportion of patients had high LIC. The burden due to heart iron overload was less prominent. Cardiac- and liver-related complications are the major causes of morbidity and mortality. From 2000 to 2015, a decrease in heart-related deaths along with an increase in liver-associated fatalities was observed. The Hellenic Prevention Program along with advances in chelation regimens and iron status monitoring have resulted in improved patient outcomes. The NRHG gives insight into the effectiveness of prevention programs, the therapeutic management of hemoglobinopathies and associated outcomes. NRHG may contribute to the formulation of a roadmap for hemoglobinopathies in Europe and promote the implementation of effective public health policies.Entities:
Keywords: Greece; Hemoglobinopathy; Registry; Sickle cell disease; Thalassemia
Mesh:
Substances:
Year: 2018 PMID: 30196444 DOI: 10.1007/s00277-018-3493-4
Source DB: PubMed Journal: Ann Hematol ISSN: 0939-5555 Impact factor: 3.673